Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Pediatric Joint Injections
NCT03069638Phase 4Completed
- Sponsor
- University of Oulu
- Start
- Feb 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in juvenile idiopathic arthritis (JIA), sponsored by University of Oulu. Started Feb 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT03069638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069638.